Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPBAR1 | Q8TDU6 | 7/20 | 0.70 |
| ▸ | EPHA2 | P29317 | 3/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.70 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.70 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.70 |
| ▸ | LMNA | P02545 | 2/20 | 0.70 |
| ▸ | EFNA1 | P20827 | 1/20 | 0.70 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.70 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.70 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.70 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.70 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.70 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.70 |
| ▸ | MEN1 | O00255 | 1/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.70 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | INPP5D | Q92835 | 1/20 | 0.52 |
| ▸ | CASP7 | P55210 | 3/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4998524 | 1.00 | GPBAR1 (0.70) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 | |
| SCHEMBL7630863 | 1.00 | GPBAR1 (0.70) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 | |
| SCHEMBL28244107 | 1.00 | GPBAR1 (0.70) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 | |
| SCHEMBL7624552 | 1.00 | GPBAR1 (0.70) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 | |
| SCHEMBL7623866 | 1.00 | GPBAR1 (0.70) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 | |
| SCHEMBL7863453 | 1.00 | GPBAR1 (0.70) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 | |
| SCHEMBL7623813 | 1.00 | GPBAR1 (0.70) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 | |
| SCHEMBL14677573 | 1.00 | GPBAR1 (0.70) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 | |
| SCHEMBL7623815 | 1.00 | GPBAR1 (0.70) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 | |
| SCHEMBL28088042 | 0.93 | EPHA2 (0.67) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 827 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210367155-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2021-11-25 | — | — | US | claimed |
| EP-3571264-B1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2021-11-24 | — | — | EP | claimed |
| CN-109134573-B | Ergostane steroid compound, preparation method and application thereof | 中国科学院上海药物研究所 | 2021-03-23 | — | — | CN | claimed |
| WO-2018134392-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2018-07-26 | — | — | WO | claimed |
| US-20170226150-A1 | TRITERPENOID COMPOSITION OF ANTRODIA CINNAMOMEA, PREPARATION AND ANALYSIS METHOD THEREOF | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2017-08-10 | — | — | US | claimed |
| US-20160318972-A1 | PREPARATION METHOD AND ANALYTIC METHOD FOR THE EXTRACT OF ANTRODIA CINNAMOMEA | Wu, Yang-Chang (TW) | 2016-11-03 | — | — | US | claimed |
| CN-104932032-A | Discrimination method for charging period of underground biodegradation heavy oil reservoir | UNIV CHINA PETROLEUM | 2015-09-23 | — | — | CN | claimed |
| CN-104673676-A | Harmful mycogone perniciosa and ergot sterane type triterpenoid prepared by fermentation as well as method | TIANJIN INST IND BIOTECHNOLOGY CAS | 2015-06-03 | — | — | CN | claimed |
| CN-104359933-A | Triterpenoid composition of antrodia cinnamomea fruiting body, preparation and analysis method | UNIV KAOHSIUNG MEDICAL | 2015-02-18 | — | — | CN | claimed |
| US-20120190871-A1 | TRITERPENOID COMPOSITION OF ANTRODIA CINNAMOMEA, PREPARATION AND ANALYSIS METHOD THEREOF | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2012-07-26 | — | — | US | claimed |
| US-20120087872-A1 | Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof | FOAMIX LTD. (IL) | 2012-04-12 | — | — | US | claimed |
| WO-2010125470-A2 | FOAMABLE VEHICLE AND PHARMACEUTICAL COMPOSITIONS COMPRISING APROTIC POLAR SOLVENTS AND USES THEREOF | FOAMIX LTD. (IL) | 2010-11-04 | — | — | WO | claimed |
| WO-2006045171-A2 | PROCESS FOR OBTAINING DRY STEROIDS DERIVATIVE FROM ERGOSTANE | Fundação Oswaldo Cruz (Fiocruz) (BR) | 2006-05-04 | — | — | WO | claimed |
| US-20020007079-A1 | MEIOSIS REGULATING COMPOUNDS | NOVO NORDISK A/S (DK) | 2002-01-17 | — | — | US | claimed |
| EP-1087988-A1 | MEIOSIS REGULATING COMPOUNDS | NOVO NORDISK A/S (DK) | 2001-04-04 | — | — | EP | claimed |
| WO-1999067273-A1 | MEIOSIS REGULATING COMPOUNDS | NOVO NORDISK A/S (DK) | 1999-12-29 | — | — | WO | claimed |
| JP-6305970-A | — | — | None | — | — | JP | disclosed |
| EP-4401740-B1 | USE OF TERPENOIDS IN THE TREATMENT OF MASTOCYTOMA | ARJIL BIOTECH HOLDING COMPANY LTD (TW) | 2026-04-01 | — | — | EP | disclosed |
| US-3998859-A | Introducing Δ11 unsaturation into steroid compounds | EASTMAN KODAK COMPANY (US) | 1976-12-21 | — | — | US | disclosed |
| US-3931167-A | Process for the manufacture of 3-keto-6-azido-4,6-bis-dehydro-steroids and intermediates useful therein | SCHERING CORPORATION (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020007079-A1 | MEIOSIS REGULATING COMPOUNDS | CYP11A1, NR5A1, MNS1 | GPBAR1 657/4885EPHA2 3823/4885HSD17B10 69/4885 |
| US-20170226150-A1 | TRITERPENOID COMPOSITION OF ANTRODIA CINNAMOMEA, PREPARATION AND ANALYSIS METHOD THEREOF | CYP51A1, LSS, ERG28 | GPBAR1 2072/4885EPHA2 3987/4885HSD17B10 139/4885 |
| US-20210367155-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | EPB41, EPB41L2, MCM4 | GPBAR1 2998/4885EPHA2 751/4885HSD17B10 2458/4885 |
| US-20120190871-A1 | TRITERPENOID COMPOSITION OF ANTRODIA CINNAMOMEA, PREPARATION AND ANALYSIS METHOD THEREOF | CYP51A1, LSS, ERG28 | GPBAR1 2072/4885EPHA2 3987/4885HSD17B10 139/4885 |
| US-20160318972-A1 | PREPARATION METHOD AND ANALYTIC METHOD FOR THE EXTRACT OF ANTRODIA CINNAMOMEA | CYP51A1, LSS, ERG28 | GPBAR1 2007/4885EPHA2 4741/4885HSD17B10 324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.